Assiut University: Carcinoma trials

The registry lists 25 Carcinoma studies with Assiut University as lead sponsor. 9 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 1Phase 2 1Phase 3 1No phase 22(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Role of Maspin in Colorectal Carcinoma, an Immunohistochemical StudyNot yet recruitingNCT06915350
• Role of Cytomorphometry and BRAFV600E Immunocytochemistry With a Cytologic Diagnosis "Suspicious for Papillary Thyroid Carcinoma"Not yet recruitingNCT06901908
• Exploring the Knowledge, Attitudes, Behaviors and Perceived Barriers of Hepatologists Towards Non-invasive Hepatocellular Carcinoma Prediction Models in Hepatitis C Patients Who Achieved Sustained Virological Response Following Direct Acting Antivirals TherapyNot yet recruitingNCT06872047
• Characteristic and Survival Outcomes in Hepatocellular Carcinoma Patients: on Top of Viral Hepatitis Versus Combined Viral and Metabolic-Associated Steatotic Liver DiseaseNot yet recruitingNCT06871930
• Clinicopathological Features of Renal Cell Carcinoma in Young PatientsNot yet recruitingNCT06730997
• Clinicopathological Analysis of Endometrial Carcinoma in the View of Old and New International Federation of Gynecology and Obestetrics (FIGO)RecruitingNCT06632431
• Transfemoral Versus Transradial Approach in Transarterial Chemoembolization of Hepatocellular CarcinomaNot yet recruitingNCT06543030
• Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular CarcinomaRecruitingNCT06527495Phase 1/2
• Role of Abbreviated MRI in Follow-up of Hepatocellular Carcinoma .Not yet recruitingNCT06168357
• Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.Status unknownNCT05832593
• Immunohistochemical Evaluation of DNA Methylation and Histone Modification in H. Pylori Associated Gastric CarcinomaStatus unknownNCT05811546
• A Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary BladderStatus unknownNCT05503563
• Outcome of Hepatocellular Carcinoma Patients With Portal Vein Thrombosis After Trans-Arterial Chemo EmbolizationStatus unknownNCT05491889
• Multi-Detector CT Angiography With 3D Reconstruction Versus Digital Subtraction AngiographyCompletedNCT05304572
• Effect of Accelerated RTH in Squamous Cell Carcinoma in Head and NeckStatus unknownNCT05291663
• Outcome of Radiation Therapy in Urinary Bladder Squampus Cell CarcinomaStatus unknownNCT04815629
• Concurent Chemoradiotherapy in Head and Neck CancersStatus unknownNCT04780750Phase 3
• Evaluation of Liver Stiffness by Ultrasound Elastography for Predicting Early HCC Recurrence After TreatmentStatus unknownNCT04552236
• Vasculogenic Mimicry in Urothelial CarcinomaStatus unknownNCT04295967
• Epigenetic Changes in Hepatocellular Carcinoma Developed After Direct Acting Antiviral Therapy for Chronic Hepatitis CStatus unknownNCT04220151
• Effectiveness of Drug Eluting TACE in Primary HCCStatus unknownNCT04048317Early Phase 1
• Definitive Concurrent Hypofractionated Rth With Weekly Cisplatin in Locally Advanced SCCHNCompletedNCT03880396
• The Assesment of MMP-1 Genotypes Polymorphism as a Risk Factor for HCC in Chronic HCV Patients With LCStatus unknownNCT03722628
• Role of Geminin and Mcm-2 in Prognosis of Renal Cell CarcinomaStatus unknownNCT03692533Not applicable
• Role of LDH as a Predictor of Treatment Outcomes in Hepatocellular CarcinomaStatus unknownNCT03338166